Consistently, in vivo studies have shown that loss of miR-192 was associated with the development and progression of DKD through exacerbation of kidney fibrosis by enhancing TGF-β1 signalling pathway [116]. This evidence concerns the gene TGFB1 and diabetic kidney disease.